Judith Dunn

Judith Dunn

Director/Board Member at CLIMB BIO, INC.

Net worth: - $ as of 30/06/2026

63 year
Health Technology
Consumer Services
Commercial Services

Profile

Judith A. Dunn is Director at BioIVT LLC since 2024.
Independent Non-Executive Director at Evolution Research Group LLC since 2018.
Independent Director at Climb Bio, Inc. since 2021.
Director at The Partnership Fund For New York City.
Head-Research & Development at Vima (Texas) since 2023.
Formerly Chairman at New York Biotechnology Association, Inc. from 2016 to 2018.
Executive Medical Director at Sumitomo Pharma America, Inc. from 2005 to 2010.
Independent Director at Seelos Therapeutics, Inc. from 2020 to 2021.
Vice President-Research & Development at F.
Hoffmann-La Roche Ltd. from 2014 to 2018.
President & Head-Research & Development at Fulcrum Therapeutics, Inc. from 2021 to 2023.
Educated at Rochester Christian University (undergraduate) and Wesleyan University (doctorate).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
05/06/2026 0 ( -.--% ) - $ 30/06/2026

Judith Dunn active positions

CompaniesPositionStart
CLIMB BIO, INC. Director/Board Member 01/02/2021
Director/Board Member 01/08/2018
Director/Board Member 01/01/2024

Former positions of Judith Dunn

CompaniesPositionEnd
FULCRUM THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 01/01/2023
SEELOS THERAPEUTICS, INC. Director/Board Member 01/09/2021
Chairman 01/06/2018
Chief Tech/Sci/R&D Officer 01/01/2018
Corporate Officer/Principal 01/01/2010
See the detail of Judith Dunn's experience

Training of Judith Dunn

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

63

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Consumer Services

Health Technology

Consumer Services

Commercial Services

Health Services

Commercial Services

Health Technology

Health Technology

Health Technology